The link between TMPRSS2 expression and immune response-relevant profiles was further validated by in silico analyses of cancer genome databases with a positive correlation between TMPRSS2 and the expression of HLA-I APM and IFN type I and II pathway genes (Supplementary Table 3). This evidence concerns the gene ANPEP and cancer.